Adherence to oral chemotherapy medications among gastroenterological cancer patients visiting an outpatient clinic

被引:20
作者
Hirao, Chieko [1 ]
Mikoshiba, Naoko [1 ]
Shibuta, Tomomi [1 ]
Yamahana, Reiko [1 ]
Kawakami, Aki [1 ]
Tateishi, Ryosuke [2 ]
Yamaguchi, Hironori [3 ]
Koike, Kazuhiko [2 ]
Yamamoto-Mitani, Noriko [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Gerontol Home Care & Long Term Care Nursing, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Jichi Med Univ, Dept Clin Oncol, Shimotsuke, Tochigi, Japan
关键词
gastroenterological cancer; medication adherence; oral chemotherapy medications; outpatients; ANTINEOPLASTIC AGENTS; THERAPY; NONADHERENCE; DETERMINANTS; MORTALITY; COHORT; WOMEN;
D O I
10.1093/jjco/hyx087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The purpose of this study was to investigate medication adherence to oral chemotherapy medications and determinants of medication non-adherence to them among gastroenterological cancer patients. Methods: A cross-sectional study was conducted on 117 consecutive, consenting, eligible patients visiting an outpatient clinic of university hospital in Japan. Good medication adherence was defined as taking 100% of the prescribed dose. Medication adherence was measured via self-report. We hypothesized that there was a significant relationship between medication non-adherence and the five factors defined by the World Health Organization: patient-related, socioeconomic-related, condition-related, treatment-related, and healthcare-system/provider-related factors. Multiple logistic regression models were used to identify factors associated with oral chemotherapy medication non-adherence. Results: The proportion of patients showing good medication adherence was 56.4%. The multiple logistic regression analysis revealed that the determinants of medication non-adherence to oral chemotherapy medications included having a history of patient-caused treatment interruptions due to worsening of symptoms (adjusted odds ratio [AOR] = 9.59, 95% confidence interval [CI] = 1.38-66.47), having diarrhea (AOR = 3.25, 95% CI = 1.13-9.34), experiencing pain (AOR = 0.17, 95% CI = 0.05-0.55), taking oral chemotherapy medication every 8 h (AOR = 5.52, 95% CI = 1.71-17.81), and diminished sense of priority for medication (AOR = 1.40, 95% CI = 1.21-1.63). Conclusions: This study suggests that many patients with gastroenterological cancer were non-adherent to oral chemotherapy medications. It might be necessary to conduct periodic screening and connect patients at a high risk of medication non-adherence to appropriate support.
引用
收藏
页码:786 / 794
页数:9
相关论文
共 50 条
[41]   Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer [J].
Salloum, Ramzi G. ;
Smith, Thomas J. ;
Jensen, Gail A. ;
Lafata, Jennifer Elston .
LUNG CANCER, 2012, 75 (02) :255-260
[42]   Evaluation of an Outpatient Pharmacy Clinical Services Program on Adherence and Clinical Outcomes Among Patients with Diabetes and/or Coronary Artery Disease [J].
Spence, Michele M. ;
Makarem, Abir F. ;
Reyes, Stacie L. ;
Rosa, Lisa L. ;
Nguyen, Courtney ;
Oyekan, Elizabeth A. ;
Kiyohara, Alan T. .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (10) :1036-1045
[43]   Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution [J].
Hwang, Grace S. ;
Paranjpe, Rutugandha ;
Opsomer, Carine ;
Lu, Kelvin ;
Abajue, Uzoamaka ;
Abughosh, Susan ;
Zaghloul, Hanna ;
Trivedi, Meghana, V .
CLINICAL BREAST CANCER, 2020, 20 (06) :520-526
[44]   The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression [J].
Xing, Shan ;
Calip, Gregory S. ;
Leow, Alex D. ;
Kim, Shiyun ;
Schumock, Glen T. ;
Touchette, Daniel R. ;
Lee, Todd A. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (05) :492-500
[45]   Adherence to oral anticancer treatments: network and sentiment analysis exploring perceived internal and external determinants in patients with metastatic breast cancer [J].
Masiero, M. ;
Spada, G. E. ;
Fragale, E. ;
Pezzolato, M. ;
Munzone, E. ;
Sanchini, V. ;
Pietrobon, R. ;
Teixeira, L. ;
Valencia, M. ;
Machiavelli, A. ;
Woloski, R. ;
Marzorati, C. ;
Pravettoni, G. .
SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
[46]   Use of Complementary and Alternative Medications among Patients in an Obstetrics and Gynecology Clinic [J].
Smith, Judith A. ;
Badell, Martina L. ;
Kunther, Anuradha ;
Palmer, J. Lynn ;
Dalrymple, John L. ;
Ramin, Susan M. .
JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (9-10) :390-396
[47]   Medication Adherence and the Risk of Cardiovascular Mortality and Hospitalization Among Patients With Newly Prescribed Antihypertensive Medications [J].
Kim, Soyeun ;
Shin, Dong Wook ;
Yun, Jae Moon ;
Hwang, Yunji ;
Park, Sue K. ;
Ko, Young-Jin ;
Cho, BeLong .
HYPERTENSION, 2016, 67 (03) :506-512
[48]   Factors Contributing to Lack of Adherence to Antihypertensive Medications Among Patients at Nishtar Hospital in Multan, Pakistan [J].
Khan, Allahdad ;
Maqbool, Ayesha ;
Khan, Ahmed A. ;
Jamil, Muhammad Farhan ;
Aziz, Beshair ;
Aziz, Aamir ;
Khan, Jawad A. ;
Riaz, Muhammad Hamza ;
Naeem, Wania ;
Rasheed, Ahsan .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
[49]   Adherence to Medication among Parkinson's Disease Patients Using the Adherence to Refills and Medications Scale [J].
Radojevic, Branislava ;
Dragasevic-Miskovic, Natasa T. ;
Milovanovic, Andona ;
Svetel, Marina ;
Petrovic, Igor ;
Pesic, Maja ;
Tomic, Aleksandra ;
Stanisavljevic, Dejana ;
Savic, Miroslav M. ;
Kostic, Vladimir S. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022 :6741280
[50]   Factors Influencing Adherence in Cancer Patients Taking Oral Tyrosine Kinase Inhibitors A Qualitative Study [J].
Verbrugghe, Mathieu ;
Duprez, Veerle ;
Beeckman, Dimitri ;
Grypdonck, Mieke ;
Quaghebeur, Marijke ;
Verschueren, Caroline ;
Verhaeghe, Sofie ;
Van Hecke, Ann .
CANCER NURSING, 2016, 39 (02) :153-162